Treatment of Paracetamol (Acetaminophen) Poisoning
Immediate Management: N-Acetylcysteine (NAC) is the Cornerstone
Administer N-acetylcysteine immediately to all patients with suspected or confirmed paracetamol poisoning when serum levels plot above the "possible toxicity" line on the Rumack-Matthew nomogram, when timing is unknown, or when hepatotoxicity is already present—ideally within 8 hours of ingestion to maximize efficacy. 1
Critical Time Windows for NAC Efficacy
The effectiveness of NAC is dramatically time-dependent:
- 0-8 hours post-ingestion: Only 2.9% develop severe hepatotoxicity when treated within this window 1
- 8-10 hours: Risk increases to 6.1% 1
- 10-24 hours: Risk jumps to 26.4% 1
- Beyond 24 hours: NAC still provides benefit and reduces mortality, though efficacy is significantly diminished 1
Never withhold NAC even in late presentations (>24 hours), as it reduces mortality from 80% to 52% in fulminant hepatic failure regardless of time since ingestion. 1
Initial Assessment and Risk Stratification
Laboratory Evaluation (Obtain Immediately)
- Serum paracetamol level (must be drawn ≥4 hours post-ingestion for accurate nomogram interpretation) 2
- Liver function tests: AST, ALT, alkaline phosphatase, total bilirubin 3, 2
- Coagulation studies: INR/prothrombin time 3, 2
- Renal function: Creatinine, BUN 2
- Metabolic panel: Glucose, electrolytes, arterial lactate 3
- Arterial blood gas 3
Using the Rumack-Matthew Nomogram
The nomogram applies ONLY to single acute ingestions with known time of ingestion when levels are drawn 4-24 hours post-ingestion. 1, 2
- Plot the paracetamol concentration against time post-ingestion 1
- Treatment line: Starts at 150 mg/L (992 µmol/L) at 4 hours, extending to 24 hours with a half-life of 4 hours 4
- Treat all patients at or above the "possible toxicity" line 1, 2
Critical pitfall: The nomogram does NOT apply to repeated supratherapeutic ingestions, extended-release formulations, or presentations >24 hours post-ingestion 1
NAC Dosing Regimens
Intravenous Protocol (Preferred in Most Settings)
Two-bag regimen (current recommendation): 5
- First dose: 200 mg/kg in 5% dextrose over 4 hours
- Second dose: 100 mg/kg over 16 hours (total 20-hour protocol)
Traditional three-bag regimen: 1, 2
- Loading dose: 150 mg/kg over 15 minutes (or more slowly over 1-2 hours to reduce anaphylactoid reactions)
- Second dose: 50 mg/kg over 4 hours
- Third dose: 100 mg/kg over 16 hours (total 21-hour protocol)
Oral Protocol (Alternative)
- Loading dose: 140 mg/kg by mouth or nasogastric tube 1
- Maintenance: 70 mg/kg every 4 hours for 17 additional doses (total 72 hours) 1
The oral regimen may be superior when treatment is delayed and is as effective as IV NAC. 1
Activated Charcoal
Give activated charcoal (1 g/kg orally) just prior to starting NAC if the patient presents within 4 hours of ingestion. 1, 2
- Most effective within 1-2 hours but may provide benefit up to 4 hours 1
- Ensure airway protection, especially with co-ingestions 1
Special Clinical Scenarios
Unknown Time of Ingestion
Start NAC loading dose immediately without waiting for laboratory results. 1, 2
- Obtain paracetamol level to guide continuation of therapy 2
- Treat if any detectable paracetamol level is present 1
Delayed Presentation (>24 Hours Post-Ingestion)
Administer NAC immediately based on clinical presentation and laboratory findings rather than nomogram placement. 1
- The nomogram is invalid in this timeframe 1
- Base treatment decisions on paracetamol levels, transaminases, and INR 1
- Continue NAC until transaminases are declining and INR normalizes 1
Established Hepatotoxicity or Fulminant Hepatic Failure
All patients with acute liver failure suspected to be from paracetamol must receive NAC immediately, regardless of time since ingestion (Level B recommendation). 1
- NAC reduces mortality from 80% to 52% 1
- Reduces cerebral edema from 68% to 40% 1
- Reduces need for inotropic support from 80% to 48% 1
- Contact liver transplant center immediately 3
- Requires ICU-level care 1, 3
Repeated Supratherapeutic Ingestions (RSTI)
Treat with NAC if: 1
- ≥10 g or 200 mg/kg (whichever is less) during a single 24-hour period, OR
- ≥6 g or 150 mg/kg (whichever is less) per 24-hour period for ≥48 hours, OR
- Serum paracetamol ≥10 mg/mL, OR
- AST or ALT >50 IU/L
The nomogram does not apply to RSTI—use clinical judgment and laboratory values. 1
Extended-Release Paracetamol
Obtain two paracetamol levels: 1, 2
- First at 4 hours post-ingestion
- Second at 8-10 hours post-ingestion
Treat with full NAC course if either level is at or above the treatment line. 2
Massive Overdoses
For paracetamol concentrations more than double the nomogram line, increase NAC dosing beyond standard protocol. 1, 5
- Consider step-wise increases at the 300-, 450-, and 600-lines on the nomogram 1
- Patients ingesting ≥30 g or ≥500 mg/kg should receive increased doses 5
High-Risk Populations (Lower Treatment Threshold)
Treat even with paracetamol levels in the "non-toxic" range for: 1
- Chronic alcohol consumption: Severe hepatotoxicity documented with doses as low as 4-5 g/day 1, 6
- Malnutrition or fasting states 1
- Pre-existing liver disease 6, 3
- CYP2E1 enzyme-inducing drugs (e.g., isoniazid) 2
Criteria for Stopping NAC
NAC can be discontinued when ALL of the following criteria are met: 1
- Paracetamol level is undetectable
- AST and ALT are normal or declining
- INR is normal
- Patient is asymptomatic
Red flags that mandate continuing or restarting NAC: 1
- Any elevation in AST or ALT above normal
- Rising transaminases
- Any coagulopathy (elevated INR)
- Detectable paracetamol level
- Clinical signs of hepatotoxicity
For delayed presentations, extended-release formulations, RSTI, or unknown timing, continue NAC beyond the standard protocol until criteria above are met. 1
Critical Warning Signs Requiring Immediate Escalation
Very high aminotransferases (AST/ALT >3,500 IU/L) are highly correlated with paracetamol poisoning even without clear overdose history. 6, 3
Immediate ICU transfer and transplant hepatology consultation if: 1, 3
- AST/ALT >1,000 IU/L
- Coagulopathy (elevated INR)
- Altered mental status or hepatic encephalopathy
- Hypoglycemia
- Elevated arterial lactate
- Renal dysfunction
Clinical Presentation Timeline
Understanding the temporal progression helps guide management:
- 0-24 hours: Nonspecific symptoms (nausea, vomiting, malaise); may be asymptomatic 3
- 24-72 hours: Liver enzymes begin rising; jaundice may appear; right upper quadrant tenderness variably present 3
- 72-96 hours: Maximum liver damage; AST/ALT potentially in thousands; coagulopathy develops 3
Early recognition is critical as liver damage may not be apparent until 24-72 hours post-ingestion. 3
Common Pitfalls to Avoid
- Do not wait for paracetamol levels if presentation is >8 hours post-ingestion—start NAC immediately 1, 2
- Low or absent paracetamol levels do not rule out poisoning if ingestion was remote or occurred over several days 1, 6
- Do not rely on patient-reported ingestion quantity—it is often inaccurate 2
- Do not use the nomogram for RSTI, extended-release formulations, or presentations >24 hours 1
- Even therapeutic doses (4 g/day for 14 days) can cause ALT elevations >3× normal in 31-41% of healthy adults 6